Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06116149 · ClinicalTrials.gov registry record · NA

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics

A NA study of Obesity and PreDiabetes, sponsored by Tulane University.

Recruiting
Registry status
NA
Development phase
722
Enrollment target
1
Study location

NCT06116149: Recruiting NA study of Obesity and PreDiabetes, sponsored by Tulane University.

NCT06116149 is a NA study of Obesity and PreDiabetes that is actively recruiting participants, run by Tulane University. The registered enrollment target is 722 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06116149, a NA study of Obesity and PreDiabetes, is actively recruiting participants, sponsored by Tulane University.

RECRUITING
Registry status
NA
Development phase
722 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the STRIVE study is to compare two implementation strategies for Diabetes Prevention Program delivery: an in-person health coach strategy (standard 24 in-person sessions at WIC clinics) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person sessions at WIC clinics supplemented by technology support) on implementation and health-related outcomes in postpartum women.

Primary Outcome

The primary implementation outcome will be the difference between study arms in a composite uptake score, as defined by a composite score consisting of the percent of sessions attended and the percentage of times in which participants record weight, activity, and diet compared to what is recommended by the intervention.

Interventions

  • BEHAVIORAL In-person health coach delivery of the GLB
  • BEHAVIORAL Technology-assisted health coach delivery of the GLB

Study Locations (1)

Louisiana

  • Tulane University School of Public Health and Tropical Medicine - New Orleans

Trial Details

FieldValue
Enrollment Target 722 participants
Start Date 2023-12-12
Est. Completion 2027-04
Phase NA
Tulane University

73 total trials

What NCT06116149 shows while recruiting

NCT06116149 is an interventional study that assigns participants to a tested intervention. The registered 722 participants enrollment target is mid-sized for trials with a published cap, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (12% lower).

The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which In-person health coach delivery of the GLB is the first listed.

NCT06116149 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT06116149 about?

NCT06116149 is a clinical study titled "Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics". The primary objective of the STRIVE study is to compare two implementation strategies for Diabetes Prevention Program delivery: an in-person health coach strategy (standard 24 in-person sessions at WIC clinics) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person...

What is the current status of trial NCT06116149?

This trial is currently recruiting. It is a NA study. The enrollment target is 722 participants. The study started on 2023-12-12. Estimated completion is 2027-04.

What conditions does trial NCT06116149 study?

This clinical trial studies the following conditions: Obesity, PreDiabetes, Gestational Diabetes, Hyperglycemia, Lifestyle, Healthy.

What interventions are being tested in trial NCT06116149?

The interventions under investigation include: In-person health coach delivery of the GLB (BEHAVIORAL), Technology-assisted health coach delivery of the GLB (BEHAVIORAL).

Who is sponsoring clinical trial NCT06116149?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06116149 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06116149's enrollment target sits among peer trials

722 104th of 1053 higher than 950 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06641466 · 723 participants · Phase 3

    A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

  • NCT07088068 · 723 participants · Phase 3

    A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • NCT06664619 · 724 participants · Phase 3

    A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • NCT04916327 · 720 participants · NA

    Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06116149, the US trial registry maintained by the National Library of Medicine. NCT06116149 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.